eurocvp 2015 Congress
Roma, 29-31 de mayo de 2015
Más información
Gender differences in cardiovascular pharmacology.
Moderador: Dr. Juan Tamargo
"Can we generalise to both gender the results of cardiovascular clinical trials?". Ponente: Dr. Juan Tamargo
Pharmacotherapy of Heart Failure - Joint sessions with the Heart Failure Association
"What is on the horizon for the pharmacological treatment of patients with chronic heart failure after PARADIGM-HF".
Ponente: Dr. Juan Tamargo Menéndez
Panel discussion: NOAC antidotes
Moderador: Dr. Juan Tamargo Programa
|